Tonix Holdings Slides 5.5% as Market Volatility Hits CNS Pharma Stocks
Tonix Holdings drops 5.5% as investors track its CNS drug pipeline; learn how the 200‑day SMA and peer moves could signal a rebound.
- TONIX PHARMACEUTICALS HOLDIN
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read